Orbactiv

Product NDC
70842-140
11-digit product format
708420140
Labeler code
70842
Product ID
70842-140_4c7649f3-4d38-47e2-aa0d-2ed606bb930a
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
oritavancin
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS
Labeler
Melinta Therapeutics, LLC
Application
NDA206334
Marketing category
NDA
Marketing start
2014-09-01
Substance
ORITAVANCIN
Active strength
400 mg/1
Pharmacologic classes
Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 2D6 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Lipoglycopeptide Antibacterial [EPC], Lipoglycopeptides [CS]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Additional Listing Data#

Finished product
Yes
Brand name base
Orbactiv
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
ORITAVANCIN400 mg/1

Harmonized Identifiers#

Field, Values table
FieldValues
UniiPUG62FRZ2E
Rxcui1547615, 1547620

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
379b20c4-7e52-4276-8a8d-fc6efc44abd4Product name120210903
8b844746-3ad0-4fdc-869e-bb322f11fbbaProduct name120141209

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
70842-140-01Orbactiv1 in 1 VIAL, GLASSINJECTION, POWDER, LYOPHILIZED,112
70842-140-03Orbactiv3 in 1 CARTONINJECTION, POWDER, LYOPHILIZED,312

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
70842-140-01EA - Each70842-14006ddb6c2-abad-4449-9740-234b40dc37c912018-07-03
70842-140-03EA - Each70842-1400a0ff11b-941a-452b-8a1d-e04a9be5eb6a12018-07-03

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
70842-140ORBACTIV (ORITAVANCIN) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [MELINTA THERAPEUTICS, LLC]11Current NDC, Legacy NDC, 2 package rows20241222_ff09a726-9f9b-4e30-b509-396781293220.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
1547620Orbactiv 400 MG InjectionPSNff09a726-9f9b-4e30-b509-39678129322012
1547615oritavancin 400 MG InjectionPSNff09a726-9f9b-4e30-b509-39678129322012
1547620oritavancin 400 MG Injection [Orbactiv]SBDff09a726-9f9b-4e30-b509-39678129322012
1547615oritavancin 400 MG InjectionSCDff09a726-9f9b-4e30-b509-39678129322012
1547620Orbactiv (as oritavancin diphosphate) 400 MG InjectionSYff09a726-9f9b-4e30-b509-39678129322012
1547620Orbactiv 400 MG InjectionSYff09a726-9f9b-4e30-b509-39678129322012
1547615oritavancin (as oritavancin diphosphate) 400 MG InjectionSYff09a726-9f9b-4e30-b509-39678129322012

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startMarketing endSampleExclude flagStatus
70842-140-01708420140011 in 1 VIAL, GLASSHistorical
70842-140-03708420140033 VIAL, GLASS in 1 CARTON (70842-140-03) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, GLASS (70842-140-01) 2014-09-010000-00-00NoNoCurrent